Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Clinical Lung Cancer|August 16, 2021
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma PatientsJordi Remon, Nicolas Girard, Silvia Novello, et al.
British Journal of Pharmacology|June 7, 2023
Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?Alicia García-Culebras, María Isabel Cuartero, Carolina Peña-Martínez, et al.
Anticancer Research|March 8, 2019
Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung CancerAna Laura Ortega-Granados, Ángel Artal-Cortes, David Aguiar-Bujanda, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2021
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumorsFelipe K Hurtado, Filippo de Braud, Javier De Castro Carpeño, et al.
Oncology and Therapy|January 15, 2022
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisEdurne Arriola, María González-Cao, Manuel Domine, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 8, 2006
Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive ratsBeatriz Gálvez, Javier de Castro, Diana Herold, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 22, 2025
Monitoring of the oncological process for lung cancer in Spain: an expert consensus reportJavier de Castro, Patricia Alonso-Fernández, José Javier Castrodeza, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2012
Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: baseline results of an observational study (FRAME)Philipp A Schnabel, Egbert Smit, Javier de Castro Carpeño, et al.
Oncotarget|October 6, 2017
Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancersAnna Bordas, José Luis Cedillo, Francisco Arnalich, et al.
Biomedicines|May 28, 2022
Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung CancerKarla Montalbán-Hernández, José Carlos Casalvilla-Dueñas, Patricia Cruz-Castellanos, et al.
Pageof 18